- Home
- MARPS vs NDRA Comparison
MARPS vs NDRA Comparison
Compare MARPS & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MARPS
- NDRA
- Stock Information
- Founded
- MARPS 1956
- NDRA 2007
- Country
- MARPS United States
- NDRA United States
- Employees
- MARPS N/A
- NDRA N/A
- Industry
- MARPS Oil & Gas Production
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MARPS Energy
- NDRA Health Care
- Exchange
- MARPS Nasdaq
- NDRA Nasdaq
- Market Cap
- MARPS 9.1M
- NDRA 7.3M
- IPO Year
- MARPS N/A
- NDRA 2017
- Fundamental
- Price
- MARPS $4.65
- NDRA $5.17
- Analyst Decision
- MARPS
- NDRA Strong Buy
- Analyst Count
- MARPS 0
- NDRA 1
- Target Price
- MARPS N/A
- NDRA $38.00
- AVG Volume (30 Days)
- MARPS 17.4K
- NDRA 798.8K
- Earning Date
- MARPS 01-01-0001
- NDRA 11-14-2025
- Dividend Yield
- MARPS 7.89%
- NDRA N/A
- EPS Growth
- MARPS 2.08
- NDRA N/A
- EPS
- MARPS 0.36
- NDRA N/A
- Revenue
- MARPS $1,043,830.00
- NDRA N/A
- Revenue This Year
- MARPS N/A
- NDRA N/A
- Revenue Next Year
- MARPS N/A
- NDRA N/A
- P/E Ratio
- MARPS $12.88
- NDRA N/A
- Revenue Growth
- MARPS N/A
- NDRA N/A
- 52 Week Low
- MARPS $3.34
- NDRA $2.90
- 52 Week High
- MARPS $7.90
- NDRA $11.96
- Technical
- Relative Strength Index (RSI)
- MARPS 46.37
- NDRA 45.13
- Support Level
- MARPS $4.40
- NDRA $4.79
- Resistance Level
- MARPS $5.46
- NDRA $5.37
- Average True Range (ATR)
- MARPS 0.26
- NDRA 0.49
- MACD
- MARPS -0.03
- NDRA -0.17
- Stochastic Oscillator
- MARPS 14.62
- NDRA 19.15
About MARPS Marine Petroleum Trust Units of Beneficial Interest
Marine Petroleum Trust is a U.S based royalty trust. It provides administration and liquidation of rights to payments from oil and natural gas leases in the Gulf of Mexico. The Trust's subsidiary holds title to interests in properties which are situated offshore of Louisiana. The revenues of the trust are derived from the oil and natural gas production activities of third parties.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.